THMO
$2.27
Thermogenesis Holdings
($.06)
(2.58%)
THMO
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.10)
Revenue:  $3.88 Mil
Tuesday
Nov 17
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when THMO reports earnings?
Beat
Meet
Miss

Where is THMO's stock price going from here?
Up
Flat
Down
Stock chart of THMO
Analysts
Summary of analysts' recommendations for THMO
Score
Grade
Pivots
Resistance
$2.54
$2.50
$2.41

$2.37

Support
$2.28
$2.24
$2.15
Tweet
Growth
Description
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.